Hypothalamic-Pituitary-Adrenal Axis Study in Participants With Perennial Allergic Rhinitis

Study Title
Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Female, Maleergic Rhinitis (PAR)
Teva Identifier
BDP-AR-304
ClinicalTrials.gov Identifier
NCT01133626
Study Status
Completed
Trial Condition(s)
Perennial Female, Maleergic Rhinitis
Interventions
Drug: Placebo Nasal Aerosol | Drug: Prednisone capsules | Drug: Placebo Prednisone Capsules | Drug: Beclomethasone dipropionate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years to 45 Years
Trial Duration
06/01/2010 - 09/01/2010
Phase
Phase 3

Study Type

Interventional